Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SMX Security Matters plc (SMX) vs TransMedics Group Inc (TMDX) Price & Performance

SMX Security Matters plcTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

SMX Security Matters plc vs TransMedics Group Inc — how do they compare? SMX Security Matters plc trades at $3.79 (market cap $4.13M), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 663.4× SMX Security Matters plc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SMX Security Matters plc for 21 Days and TransMedics Group Inc for 24 Days on average.

SMXTMDX
Market Cap
$4.13M$2.74B
Volume
124,362949,331
Sector
IndustrialsHealth
52-Week High
$74.08K$150.42
52-Week Low
$3.79$61.99
Typical Hold Time
21 Days24 Days
Enterprise Value
-$27.20M$3.13B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SMX Security Matters plc

SMX trades at $3.79, down 2.82% today, amid a bearish technical signal from moving averages despite oversold RSI readings. The company reported no revenue for 2025, with a net loss of $169.18 million and negative cash flow from operations, though financing activities provided a net cash inflow. Recent news highlights SMX's focus on recycled plastic verification and digital material passports, gaining media attention from outlets like Forbes and the Boston Herald in late 2026.

The outlook is highly speculative given the absence of revenue and deep losses; investment hinges on successful commercialization of its technology. Key risks include execution challenges, cash burn, and competitive pressures in the recycling sector. Analyst sentiment is cautious due to the lack of profitability and substantial financial deficits.

TransMedics Group Inc

TMDX trades at $79.00, down 2.55% amid bearish technical signals. The stock shows strong profitability with 22.69% net margin and 36.28% ROE, though recent earnings misses and margin compression from 2025 to 2026 raise concerns. Analyst consensus remains bullish with a $99.75 price target, but multiple legal investigations into fiduciary duties create uncertainty. Revenue growth continues with 2026 guidance at $668M.

The stock presents a growth opportunity with analyst upside potential, but faces near-term headwinds from earnings volatility and legal scrutiny. Execution on 2026 guidance and resolution of governance concerns will be critical for sustained momentum. Current valuation at 20.47 P/E appears reasonable given growth prospects if operational targets are met.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SMX
71% Buy29% Sell
Avg holding period · 21 Days
TMDX
95% Buy5% Sell
Avg holding period · 24 Days

Top news

Latest headlines on both assets

About SMX Security Matters plc

SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.

Read more on SMX →

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX →